Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$170,860,165
+$50,351,540 QoQ
Shares Held
471,833
+37.8% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#98
of 3,140 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. AMGN ranks #5 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
726,199 | $871,024,939 | |
| 2 | JNJ |
Johnson & Johnson
|
2,566,595 | $651,838,132 | |
| 3 | ABBV |
AbbVie Inc.
|
1,598,568 | $402,263,651 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,030,023 | $260,857,955 | |
| 5 | AMGN |
Amgen Inc
This page
|
471,833 | $170,860,165 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,071,977 | $135,433,574 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,716,000 | $98,875,920 | |
| 8 | PFE |
Pfizer Inc
|
3,801,302 | $91,535,352 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $170,860,165 | 471,833 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $120,508,625 | 342,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89,778,514 | 274,292 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $67,076,682 | 237,692 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $52,732,717 | 188,864 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $70,369,175 | 225,868 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $79,424,045 | 304,727 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $193,861,513 | 601,662 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $180,688,585 | 578,296 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $119,006,969 | 418,567 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $281,275,723 | 976,584 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $194,111,910 | 722,250 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $80,840,368 | 364,113 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $86,004,013 | 355,756 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $98,027,753 | 373,240 | Shares | Sole | 2023-02-14 | |
| 2021-09-30 | $35,988,460 | 169,238 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,271,762 | 38,038 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $109,734,664 | 441,038 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $115,681,488 | 503,138 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $157,875,804 | 621,167 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $196,606,291 | 833,572 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $125,666,650 | 619,872 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||